Clinical Research
Clinical
Trials:
Vascular Specialists of Central Florida is participating in the
following clinical research trials:
1. The use of drug coated
stents in the peripheral vascular system to prevent restenosis.
In this Drug-Eluting Stent Trial, a surgeon makes an incision in the
groin and guides a stent to the narrowed artery with a catheter. The
stent is deployed and expands to stay in place to help keep the artery
open after the catheter is withdrawn. The stent is coated with the drug
paclitaxel, which is released into the vessel to help prevent the
renarrowing of the artery over time.
http://www.zilverptxtrial.com/treatment.html
2. Abdominal aortic
aneurysm repair with stent grafts.
Abdominal aortic aneurysms can be repaired with minimal invasive
technique using stent graft, which avoid the problems associated with
conventional surgery. Several studies involve the use of new devices to
prevent aneurysm rupture, and make the procedure available to a larger
number of patients.
http://www.endologix.com/news_2005_10_10.php
3. The use of carotid
artery stent for the treatment of carotid artery disease.
The use of carotid artery stents is a new technology and we are
involved with research into the placement of these stents to prevent
strokes.
http://www.abbottvascular.com/en_US/content/document/Fact_Sheet_Carotids_Mar07.pdf
4. The use of stem cell
for the treatment of peripheral vascular disease and to prevent leg
amputations.
Some patients with peripheral vascular disease have no good treatment
options using current surgical or endovascular techniques. Many are
faced with the future prospect of amputation. Transplantation of the
patients own stem cell from their blood may allow new vessels to grow
and prevent limb loss.
http://www.feinberg.northwestern.edu/newsworthy/2008L-January/losordo.html
http://clinicaltrials.gov/ct2/show/NCT00616980?term=act34-cli&rank=1
For more
information regarding participating in these trials ask you physician,
or call Aubrey Harman, ARNP, reseach coordinator at 407-648-4323
|
|